USA - NYSE:ORAN - US6840601065 - ADR
ChartMill assigns a Buy % Consensus number of 84% to ORAN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-17 | JP Morgan | Reiterate | Overweight |
| 2023-10-18 | Barclays | Maintains | Overweight -> Overweight |
| 2023-10-04 | B of A Securities | Upgrade | Underperform -> Buy |
| 2022-01-20 | Argus Research | Downgrade | Buy -> Hold |
| 2022-01-18 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2021-09-08 | Bernstein | Initiate | Market Perform |
| 2021-07-13 | Jefferies | Initiate | |
| 2021-07-10 | JPMorgan Chase | Initiate | |
| 2021-06-28 | Deutsche Bank | Initiate | Buy |
| 2021-06-10 | Barclays | Initiate | Sell |
| 2021-04-22 | Barclays | Initiate | Neutral |
| 2021-04-22 | Goldman Sachs | Initiate | Buy |
| 2021-02-19 | Credit Suisse | Initiate | Buy |
27 analysts have analysed ORAN and the average price target is 14.05 USD. This implies a price increase of 25.98% is expected in the next year compared to the current price of 11.15.
The consensus rating for ORANGE-SPON ADR (ORAN) is 83.7037 / 100 . This indicates that analysts generally have a positive outlook on the stock.